Anemia and reduced renal function are independent predictors of elevated serum adiponectin in elderly women

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 6, 2013, Pages 568-574

  Tsuboi, Ayaka ^a   Watanabe, Mayu ^a   Kazumi, Tsutomu ^a   Fukuo, Keisuke ^a  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Anemia; Elderly; Hyperadiponectinemia; Women

Indexed keywords

ADIPONECTIN; ALBUMIN; CREATININE; CYSTATIN C; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN;

AGED; ANEMIA; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MORTALITY; PREDICTION; PREVALENCE;

ADIPONECTIN; AGED; AGED, 80 AND OVER; ANEMIA; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; JAPAN; RENAL INSUFFICIENCY, CHRONIC;

EID: 84879496718     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.17426     Document Type: Article

References (41)

1. Szmitko PE, Teoh H, Stewart DJ, Verma S: Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol, 2007; 292: H1655-H1663
2. Bik W, Baranowska-Bik A, Wolinska-Witort E, Martynska L, Chmielowska M, Szybinska A, Broczek K, Baranowska B: The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuro Endocrinol Lett, 2006; 27: 493-500
3. Arai Y, Nakazawa S, Kojima T, Takayama M, Ebihara Y, Shimizu K, Yamamura K, Homma S, Osono Y, Gondo Y, Masui Y, Inagaki H, Kitagawa K, Hirose N: High adiponectin concentration and its role for longevity in female centenarians. Geriatr Gerontol Int, 2006; 6: 32-39
4. Atzmon G, Pollin TI, Crandall J, Tanner K, Schechter CB, Scherer PE, Rincon M, Siegel G, Katz M, Lipton RB, Shuldiner AR, Barzilai N: Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci, 2008; 63: 447-453
5. Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS: Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab, 2008; 93: 3357-3364
6. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA, 2004; 291: 1730-1737
7. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P: Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation, 2005; 112: 1756-1762
8. Dekker JM, Funahashi T, Nijpels G, Pilz S, Stehouwer CD, Snijder MB, Bouter LM, Matsuzawa Y, Shimomura I, Heine RJ: Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab, 2008; 93: 1489-1496
9. Laughlin GA, Barrett-Connor E, May S, Langenberg C: Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol, 2007; 165: 164-174
10. Wannamethee SG, Whincup PH, Lennon L, Sattar N: Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med, 2007; 167: 1510-1517
11. Poehls J, Wassel CL, Harris TB, Havel PJ, Swarbrick MM, Cummings SR, Newman AB, Satterfield S, Kanaya AM: Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study. Diabetologia, 2009; 52: 591-595
12. Woodman R, Ferrucci L, Guralnik J: Anemia in older adults. Curr Opin Hematol, 2005; 12: 123-128
13. Krabbe KS, Pedersen M, Bruunsgaard H: Inflammatory mediators in the elderly. Exp Gerontol, 2004; 39: 687-699
14. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC: Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood, 2004; 104: 2263-2268
15. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med, 2005; 352: 2049-2060
16. Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, Wetzels JF, Astor BC, Gansevoort RT, Levin A, Wen CP, Coresh J; For the Chronic Kidney Disease Prognosis Consortium.: Age and Association of Kidney Measures With Mortality and End-stage Renal Disease. JAMA, 2012; 308: 1-12
17. Tanaka M, Yoshida T, Bin W, Fukuo K, Kazumi T: FTO, abdominal adiposity, fasting hyperglycemia associated with elevated HbA1c in Japanese middle-aged women. J Atheroscler Thromb, 2012; 19: 633-642
18. Wu B, Fukuo K, Suzuki K, Yoshino G, Kazumi T: Relationships of systemic oxidative stress to body fat distribution, adipokines and inflammatory markers in healthy middle-aged women. Endocr J, 2009; 56: 773-782
19. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A: Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992
20. Japanese Society of Nephrology. Assessment of renal function in adults. In Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012, pp18-21, Tokyo-igakusha, Tokyo, Japan (in Japanese)
21. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU: The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int, 2011; 80: 17-28
22. Matsubara M, Namioka K, Katayose S: Relationships between plasma adiponectin and blood cells, hepatopancreatic enzymes in women. Thromb Haematol 2004; 91: 360-366
23. Aso Y, Suganuma R, Wakabayashi S, Hara K, Nakano T, Suetsugu M, Matsumoto S, Nakamachi T, Takebayashi K, Morita K, Inukai T: Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction. Transl Res, 2009; 154: 175-182
24. Hara K, Uchida T, Takebayashi K, Sakai Y, Inoue T, Inukai T, Takayanagi K, Aso Y: Determinants of serum high molecular weight (HMW) adiponectin levels in patients with coronary artery disease: associations with cardiorenal-anemia syndrome. Intern Med 2011; 50: 2953-2960
25. Adamczak M, Chudek J, Wiecek A: Adiponectin in patients with chronic kidney disease. Semin Dial, 2009; 22: 391-395
26. Komura N, Kihara S, Sonoda M, Maeda N, Tochino Y, Funahashi T, Shimomura I: Increment and impairment of adiponectin in renal failure. Cardiovasc Res, 2010; 86: 471-477
27. Looker HC, Krakoff J, Funahashi T, Matsuzawa Y, Tanaka S, Nelson RG, Knowler WC, Lindsay RS, Hanson RL: Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab, 2004; 89: 4010-4017
28. Tentolouris N, Doulgerakis D, Moyssakis I, Kyriaki D, Makrilakis K, Kosmadakis G, Stamatiadis D, Katsilambros N, Stathakis C: Plasma adiponectin concentrations in patients with chronic renal failure: relationship with metabolic risk factors and ischemic heart disease. Horm Metab Res, 2004; 36: 721-727
29. Risch L, Saely C, Hoefle G, Rein P, Langer P, Gouya G, Marte T, Aczel S, Drexel H: Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin Chim Acta, 2007; 376: 108-113
30. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D; MMKD Study Group.: Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol, 2005; 16: 1091-1098
31. Lin J, Hu FB, Curhan G: Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care, 2007; 30: 239-244
32. Nanayakkara PW, Le Poole CY, Fouque D, van Guldener C, Stehouwer CD, Smulders YM, van Ittersum FJ, Siegert CE, Drai J, Kostense PJ, ter Wee PM: Plasma adiponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3 -5 chronic kidney disease. Clin Nephrol, 2009; 72: 21-30
33. Isobe T, Saitoh S, Takagi S, Takeuchi H, Chiba Y, Katoh N, Shimamoto K: Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol, 2005; 153: 91-98
34. Kruger IM, Huisman HW, and Schutte AE: The relationship between adiponectin, ageing and renal function in a bi-ethnic sample. Regul Pept, 2011; 169: 58-63
35. Doumatey AP, Zhou J, Huang H, Adeleye J, Balogun W, Fasanmade O, Johnson T, Oli J, Okafor G, Amoah A, Eghan B, Agyenim-Boateng K, Acheampong J, Adebamowo C, Adeyemo A, Rotimi CN: Circulating adiponectin is associated with renal function independent of age and serum lipids in west Africans. Int J Nephrol, 2012 (in press)
36. Kawamoto R, Tabara Y, Kohara K, Miki T, Abe M, Kusunoki T, Katoh T, Ohtsuka N: Serum high molecular weight adiponectin is associated with mild renal dysfunction in Japanese adults. J Atheroscler Thromb, 2010; 17: 1141-1148
37. Perrone RD, Madias NE, Levey AS: Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem, 1992; 38: 1933-1953
38. Wasén E, Suominen P, Isoaho R, Mattila K, Virtanen A, Kivelä SL, Irjala K: Serum cystatin C as a marker of kidney dysfunction in an elderly population. Clin Chem, 2002; 48: 1138-1140
39. Kizer JR, Arnold AM, Jenny NS, Cushman M, Strotmeyer ES, Ives DG, Ding J, Kritchevsky SB, Chaves PH, Hirsch CH, Newman AB: Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study. J Gerontol A Biol Sci Med Sci, 2011; 66: 1100-1107
40. Riera-Guardia N, Rothenbacher D: The effect of thiazolidinediones on adiponectin serum level: a meta-analysis. Diabetes Obes Metab, 2008; 10: 367-375
41. Raptis AE, Bacharaki D, Mazioti M, Marathias KP, Markakis KP, Raptis SA, Dimitriadis GD, Vlahakos DV: Anemia due to coadministration of renin-angiotensin-system inhibitors and PPARγ agonists in uncomplicated diabetic patients. Exp Clin Endocrinol Diabetes, 2012; 120: 416-419